Pfizer's Obesity Drug Bet | Open Interest 9/22/2025

Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Today, visa chaos as Trump targets H-1B workers and tech scrambles to respond. Oracle shakes up the C-suite with two new co-CEOs as a TikTok deal looms. And Pfizer jumps into the obesity drug race w...

Redirecting to full article...